CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 55 filers reported holding CATALYST BIOSCIENCES INC in Q1 2018. The put-call ratio across all filers is 2.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,110,000 | -5.1% | 1,000,000 | 0.0% | 1.20% | +1.0% |
| Q2 2021 | $4,330,000 | -14.1% | 1,000,000 | 0.0% | 1.19% | +0.4% |
| Q1 2021 | $5,040,000 | +521.5% | 1,000,000 | +900.0% | 1.18% | +459.0% |
| Q1 2019 | $811,000 | -48.6% | 100,000 | -50.0% | 0.21% | -63.0% |
| Q4 2018 | $1,578,000 | -26.8% | 200,000 | 0.0% | 0.57% | +25.1% |
| Q3 2018 | $2,156,000 | -48.0% | 200,000 | -43.7% | 0.46% | -62.4% |
| Q2 2018 | $4,143,000 | -64.3% | 355,000 | -21.1% | 1.22% | -48.1% |
| Q1 2018 | $11,610,000 | – | 450,000 | – | 2.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 547,541 | $3,214,000 | 6.22% |
| ACUTA CAPITAL PARTNERS, LLC | 1,497,900 | $8,793,000 | 2.54% |
| 22NW, LP | 735,841 | $4,319,000 | 2.34% |
| Prosight Management, LP | 248,050 | $1,456,000 | 0.62% |
| Worth Venture Partners, LLC | 127,983 | $751,000 | 0.37% |
| Parkman Healthcare Partners LLC | 215,237 | $1,263,000 | 0.36% |
| Sio Capital Management, LLC | 198,714 | $1,166,000 | 0.34% |
| Amtrust Financial Services, Inc. | 50,000 | $294,000 | 0.32% |
| Nantahala Capital Management | 1,821,749 | $10,694,000 | 0.32% |
| Essex Woodlands Management, Inc. | 78,622 | $462,000 | 0.23% |